Work

Durvalumab and tremelimumab in combination with FOLFOX in patients with RAS-mutated, microsatellite-stable, previously untreated metastatic colorectal cancer (MCRC): Results of the first intermediate analysis of the phase Ib/II MEDETREME trial.

Year: 2020

Type: conference-abstract

Source: Journal of Clinical Oncology

DOI: 10.1200/jco.2020.38.15_suppl.3006

Authors: François Ghiringhelli, Benoist Chibaudel, Julien Taieb, Jaafar Bennouna, Jerome Martin-Babau, Marianne Fonck, Christophe Borg, Romain Cohen, Marion Thibaudin, Emeric Limagne, Jean-David Fumet

Institutions: Centre Georges François Leclerc, GERCOR (France), Hôpital Européen Georges-Pompidou, Centre Hospitalier Universitaire de Nantes, Centre Hospitalier Régional Universitaire de Brest, Institut Bergonié, Centre Hospitalier Universitaire de Besançon, Sorbonne Université, Assistance Publique – Hôpitaux de Paris

Language: English

Topic: Cancer Immunotherapy and Biomarkers

Subfield: Oncology

Field: Medicine

Domain: Health Sciences

SDG: Good health and well-being

Open Access status: closed

OpenAlex ID: W3032064298

Cites:

Cited by: 41

Related to: 10